Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenic function in sickle-cell diseases.

M A Zago, C Bottura

    Clinical Science (London, England : 1979)
    |September 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Sickle-cell diseases progressively impair spleen function, leading to enlargement, hypoactivity, and eventual atrophy. This spleen dysfunction evolves faster in sickle-cell anemia than other sickle-cell disease types.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2017
    Same author

    Microarray profiles of ex vivo expanded hematopoietic stem cells show induction of genes involved in noncanonical Wnt signaling.

    Genetics and molecular research : GMR·2013
    Same author

    Education, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2011
    Same author

    BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients.

    Oncogene·2010
    Same author

    Simplified Technique for Examination of Chromosomes in the Bone Marrow of Man.

    Canadian Medical Association journal·2010
    Same author

    Annexin A1 subcellular expression in laryngeal squamous cell carcinoma.

    Histopathology·2008
    Same journal

    Pertussistoxin as well as Staphylococcal superantigen induce glycolysis as energy source during  T cell activation in an adenoid organoid model.

    Clinical science (London, England : 1979)·2026
    Same journal

    Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway.

    Clinical science (London, England : 1979)·2026
    Same journal

    Edaravone Dexborneol regulates the endothelial PPARγ-PON1 axis to inhibit high-cholesterol-induced atherosclerosis.

    Clinical science (London, England : 1979)·2026
    Same journal

    HDAC9 promotes atherosclerosis by suppressing CYP7A1 and impairing hepatic cholesterol excretion.

    Clinical science (London, England : 1979)·2026
    Same journal

    Clusterin ameliorates LPS-induced ARDS by inhibiting the Wnt/β-catenin pathway.

    Clinical science (London, England : 1979)·2026
    Same journal

    Human cytomegalovirus at the maternal-fetal interface: an overview of pathogenesis, defence, and interventions.

    Clinical science (London, England : 1979)·2026
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Pediatrics

    Background:

    • Sickle-cell diseases (SCDs) are inherited blood disorders characterized by abnormal hemoglobin.
    • Spleen function is crucial for immune defense and red blood cell clearance, and is often affected in SCDs.

    Purpose of the Study:

    • To investigate the patterns and progression of splenic dysfunction in various types of sickle-cell diseases.
    • To correlate spleen function with specific hematological parameters like irreversibly sickled cells (ISC).

    Main Methods:

    • Assessed splenic function using 99mTc-labeled erythrocyte clearance and spleen scanning.
    • Quantified pitted erythrocytes and irreversibly sickled cells (ISC) via microscopy.
    • Studied patients with HbS homozygotes, sickle cell beta(0)-thalassemia, SC disease, AS heterozygotes, and controls.

    Related Experiment Videos

    Main Results:

    • Three splenic function patterns were observed: enlarged hyperactive, enlarged hypoactive, and non-functional spleen.
    • Irreversibly sickled cells (ISC) percentage was highest in sickle-cell anemia, lower in S/beta(0)-thalassemia, and minimal in SC disease.
    • Spleen function appears to decline progressively with age, from enlargement to hypoactivity and atrophy.

    Conclusions:

    • Sickle-cell diseases induce a predictable sequence of splenic dysfunction.
    • The rate of spleen atrophy is accelerated in sickle-cell anemia compared to S/beta(0)-thalassemia and SC disease.
    • Understanding spleen evolution in SCDs is vital for managing associated complications.